TRIPLE G 5MG PEN

Triple G 5 mg PEN – product information

Triple G 5 mg PEN is a peptide investigational reagent containing retatrutide, also known as LY3437943. In the scientific literature, retatrutide is described as a modern agonist of three metabolic receptors: GLP-1R, GIPR and GCGR, namely the glucagon receptor. This profile makes the compound an interesting subject for research into multi-directional incretin signalling, GPCR activity and the mechanisms regulating the cellular response.

Chemically, retatrutide is a modified peptide designed to interact simultaneously with three different receptor systems. In laboratory studies, its structure allows for the analysis of the relationships between the activation of GLP-1, GIP and glucagon receptors and the changes observed in experimental models. As a result, Triple G 5 mg PEN It serves as a valuable reference resource for projects relating to peptide pharmacology and modern multi-receptor agonists.

See also the TRIPLE G 10 MG PEN peptide reagent

The PEN format is a practical form of assay reagent, facilitating the storage, preparation and reproducible dispensing of the material under controlled laboratory conditions. The 5 mg variant can be used in comparative analyses, in vitro studies and reference procedures requiring convenient preparation of the peptide material.

In Triple G laboratories, 5 mg PEN is used exclusively as a chemical reagent for scientific research, laboratory analysis and reference purposes. The product is not intended for consumption, internal use or therapeutic applications.

Scope of research into Triple G 5 mg PEN

Scientific publications indicate that retatrutide has been studied as a molecule with a triple receptor profile, involving the activation of GLP-1, GIP and glucagon receptors. This compound has been used in studies on incretin signalling, G protein-coupled receptor activity, cAMP-dependent cellular responses, and comparisons of single-, dual- and triple-receptor agonists.

In laboratory tests Triple G 5 mg PEN It may be regarded as a reference material for analyses of the mutual influence of various metabolic receptors on cellular signalling pathways. Of particular importance is the ability to investigate the relationship between the activation of GLP-1R, GIPR and GCGR and the assessment of biological responses in controlled experimental models.

Thanks to its well-characterised receptor profile, retatrutide remains one of the most interesting research peptides in the field of modern metabolic pharmacology. Triple G 5 mg PEN can be used in projects relating to incretin receptor biology, cAMP signalling, energy metabolism and the design of new peptide molecules.

Mechanism of action at the molecular level

Retatrutide acts as a receptor agonist GLP-1R, GIPR and GCGR. These receptors belong to the family of G protein-coupled receptors, the activation of which leads to the initiation of intracellular signalling cascades, including cAMP-dependent pathways. For this reason, this compound is extensively studied in research into cellular responses and the regulation of metabolic processes.

At the molecular level, Triple G 5 mg PEN enables research into how the simultaneous activation of three receptors may influence cellular signalling, gene expression and the activity of metabolic systems. Retatrutide’s triple receptor profile makes it particularly interesting when compared with classic GLP-1 agonists and compounds with a dual GLP-1/GIP profile.

The scientific significance of Triple G 5 mg PEN

Triple G 5 mg PEN It is a valuable research reagent in projects concerning incretin receptors, multi-receptor agonists and the molecular mechanisms of metabolic regulation. Retatrutide is an example of a modern peptide designed to interact with several receptors simultaneously, making it an important reference material in comparative analyses.

The PEN format further emphasises the product’s practical nature as a laboratory reagent, particularly in procedures requiring convenient preparation and reproducible dosing of the test material. Triple G 5 mg PEN is intended solely for laboratory testing, scientific analysis and reference applications.

Scientific sources:

https://pubchem.ncbi.nlm.nih.gov/compound/Retatrutide

https://pubmed.ncbi.nlm.nih.gov/35985340/

https://pubmed.ncbi.nlm.nih.gov/36354040/